HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 01-07-2020, 09:06 AM   #1
knick
Junior Member
 
Join Date: Mar 2019
Posts: 3
Tucatinib early access

Hi all,
Given the benefit tucatinib demonstrated in patients with brain mets, I wanted to flag a trial protocol out of Seattle Genetics which is designed to provide tucatinib (possibly with trastuzumab + chemo) ahead of the anticipated FDA formal approval.
https://clinicaltrials.gov/ct2/show/NCT04220203

Wishing a happy and healthy 2020 to everybody.
knick is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 10:11 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2020, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007
free webpage hit counter